Inflammation and postinfarct remodeling:: Overexpression of IKB prevents ventricular dilation via increasing TIMP levels

被引:36
作者
Trescher, K
Bernecker, O
Fellner, B
Gyöngyösi, M
Schäfer, R
Aharinejad, S
DeMartin, R
Wolner, E
Podesser, BK
机构
[1] Med Univ Vienna, CO Inst Biomed Res, AKH Wien, Ludwig Boltzmann Inst Cardiosurg Res, A-1090 Vienna, Austria
[2] Med Univ Vienna, Dept Cardiol, Vienna, Austria
[3] Med Univ Vienna, Dept Anat & Cell Biol, Vienna, Austria
[4] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Vienna, Austria
[5] Med Univ Vienna, Dept Cardiothorac Surg, Vienna, Austria
关键词
myocardial infarction; gene therapy; nuclear factor-kappa B; extracellular matrix remodelling;
D O I
10.1016/j.cardiores.2005.11.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Nuclear factor-kappa B (NF-kappa B) orchestrates genes involved in inflammation and extracellular matrix (ECM) remodeling following myocardial infarction (MI). The objective of the present study was to investigate the effect of overexpression and mode of function of I kappa B, the natural inhibitor of NF-kappa B, on ECM remodeling in a rat model of MI. Methods: MI was induced in male Sprague-Dawley rats by ligation of the left anterior descending coronary artery (LAD) and was followed by adenovirus-mediated intramyocardial transfection of I kappa B (n = 26) or LacZ reporter genes (n = 26). Sham-operated animals (n = 14) served as controls. Results: In transthoracic echocardiography 49 days after MI, systolic and diastolic left ventricular dimensions were reduced while fractional shortening was preserved in the treatment group. Additionally, evaluation on the isolated heart showed an attenuated downward shift of pressure-volume relationships in the I kappa B group compared to LacZ. NF-kappa B p65 DNA binding activity was diminished both at 5 and 49 days post-MI in the treatment group. Five days post-MI in the treatment group, protein levels of tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 beta were significantly reduced by 72.6% and 73.2%, respectively, compared to LacZ (p < 0.05). In parallel, matrix metalloproteinase (MMP)-2 and MMP-9 levels were reduced 5 days post-MI, with MMP-9 still being decreased 49 days post-MI (p < 0.01). In contrast, tissue inhibitors of metalloproteinases (TIMP)-1, -2, and -3 were increased compared to LacZ (p < 0.01 and p < 0.05, respectively) 5 days post-MI. After 49 days, TIMP-2, -3, and -4 expressions were significantly elevated (p < 0.05). Conclusion: Reducing NF-kappa B activity via I kappa B overexpression after MI positively influences ECM remodeling by reducing MMP-2 and -9 levels while increasing TIMP-1, -2, -3, and -4 levels. Therefore, I kappa B overexpression prevents ventricular dilation and consequently preserves cardiac function. (c) 2005 European Society of Cardiology. Published by Elsevier B.V All rights reserved.
引用
收藏
页码:746 / 754
页数:9
相关论文
共 41 条
[1]   Selective downregulation of VEGF-A165, VEGF-R1, and decreased capillary density in patients with dilative but not ischemic cardiomyopathy [J].
Abraham, D ;
Hofbauer, R ;
Schäfer, R ;
Blumer, R ;
Paulus, P ;
Miksovsky, A ;
Traxler, H ;
Kocher, A ;
Aharinejad, S .
CIRCULATION RESEARCH, 2000, 87 (08) :644-647
[2]   TNF-α converting enzyme (TACE) is inhibited by TIMP-3 [J].
Amour, A ;
Slocombe, PM ;
Webster, A ;
Butler, M ;
Knight, CG ;
Smith, BJ ;
Stephens, PE ;
Shelley, C ;
Hutton, M ;
Knäuper, V ;
Docherty, AJP ;
Murphy, G .
FEBS LETTERS, 1998, 435 (01) :39-44
[3]   The transcription factor NF-κB and human disease [J].
Baldwin, AS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (01) :3-6
[4]   Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling [J].
Berry, MF ;
Woo, YJ ;
Pirolli, TJ ;
Bish, LT ;
Moise, MA ;
Burdick, JW ;
Morine, KJ ;
Jayasankar, V ;
Gardner, TJ ;
Sweeney, HL .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2004, 23 (09) :1061-1068
[5]   Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway [J].
Bond, M ;
Murphy, G ;
Bennett, MR ;
Newby, AC ;
Baker, AH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (16) :13787-13795
[6]   Inhibition of transcription factor NF-κB reduces matrix metalloproteinase-1,-3 and-9 production by vascular smooth muscle cells [J].
Bond, M ;
Chase, AJ ;
Baker, AH ;
Newby, AC .
CARDIOVASCULAR RESEARCH, 2001, 50 (03) :556-565
[7]   Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart [J].
Campbell, B ;
Adams, J ;
Shin, YK ;
Lefer, AM .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1999, 31 (02) :467-476
[8]  
Creemers EEJM, 1999, CIRCULATION, V100, P250
[9]   Matrix metalloproteinase inhibition after myocardial infarction - A new approach to prevent heart failure? [J].
Creemers, EEJM ;
Cleutjens, JPM ;
Smits, JFM ;
Daemen, MJAP .
CIRCULATION RESEARCH, 2001, 89 (03) :201-210
[10]   Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction [J].
Ducharme, A ;
Frantz, S ;
Aikawa, M ;
Rabkin, E ;
Lindsey, M ;
Rohde, LE ;
Schoen, FJ ;
Kelly, RA ;
Werb, Z ;
Libby, P ;
Lee, RT .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (01) :55-62